RecallDepth
Class III Terminated

R.E.C.K. (Ropivacaine, Epinephrine, Clonidine, Ketorolac) in Sodium Chloride solution 50 mL in 60 mL Syringe, Compounded by QuVa 519 Bloombury, NJ 08804, NDC 70092143350

Company
Quva Pharma, Inc.
Recall Initiated
April 23, 2020
Posted
July 1, 2020
Recall Number
D-1335-2020
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
17,050 syringes
Firm Location
Sugar Land, TX, United States

Reason for Recall

Presence of Particulate Matter: Fresenius Kabi recalling vials of Ketorolac

Distribution

Distributed Nationwide in the US.

Lot / Code Info

Lots: 30008721, Exp. 4/26/2020; 30008198, 30008554, Exp. 4/29/2020; 30008861, Exp. 4/30/2020; 30008859, Exp. 5/5/2020; 30008949, Exp. 5/10/2020; 30009073, Exp. 5/14/2020; 30009074, Exp. 30009138, Exp. 5/17/2020; 30009139, 30009227, Exp. 5/19/2020; 30009228, Exp. 5/20/2020; 30009387, 30009388, Exp. 5/27/2020; 30009410, 30009411, Exp. 5/28/2020; 30009413, Exp. 5/31/2020; 30009412, 30009489, Exp. 6/1/2020; 30009539, 30009563, Exp. 6/3/2020

More recalls by Quva Pharma, Inc.

View all recalls by this company →

Other recent Class III Drug recalls